Marshall Fordyce is President and Chief Executive Officer of Vera Therapeutics, Inc. (VERA). The company reported total compensation of $6,986,410 for fiscal year 2025.
| Salary | $660,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $2,356,285 |
| Option awards | $3,415,725 |
| Non-equity incentive plan | $554,400 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $6,986,410 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Vera Therapeutics, Inc. filed April 9, 2026, accession 0001140361-26-014002.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $660,000 | $0 | $2,356,285 | $3,415,725 | $554,400 | $0 | $0 | $6,986,410 |
| FY2024 | President, Chief Executive Officer and Director | $616,250 | $0 | $1,323,000 | $3,299,751 | $409,200 | $0 | $0 | $5,648,201 |
| FY2023 | President, Chief Executive Officer and Director | $585,638 | $32,450 | $0 | $2,519,595 | $292,050 | $0 | $0 | $3,429,733 |
Totals as disclosed in each year's own compensation disclosure for Vera Therapeutics, Inc..
| Peer-group chief executive median | $9,029,125 |
|---|---|
| Difference from that median | $-2,042,714 |
| Percentile within the disclosed peer group | 31st |
| Peers with a disclosed figure | 16 |
Medians and percentiles are computed across the peer group Vera Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Marshall Fordyce this page | President and Chief Executive Officer | $6,986,410 |
| David Johnson | Chief Operating Officer | $2,721,412 |
| Robert Brenner | Chief Medical Officer | $2,719,852 |
| Sean Grant | Chief Financial Officer | $2,716,732 |
| William Turner | Chief Regulatory Officer | $2,346,180 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Vera Therapeutics, Inc. compensation brief.
Marshall Fordyce's compensation sits inside Vera Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.